Takeda Pharmaceutical Co Stock Price on November 26, 2024
| TAK Stock | USD 13.57 0.13 0.97% |
Below is the normalized historical share price chart for Takeda Pharmaceutical Co extending back to March 06, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Takeda Pharmaceutical stands at 13.57, as last reported on the 29th of November, with the highest price reaching 13.63 and the lowest price hitting 13.49 during the day.
If you're considering investing in Takeda Stock, it is important to understand the factors that can impact its price. Takeda Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.12, which indicates the firm had a -0.12% return per unit of risk over the last 3 months. Takeda Pharmaceutical Co exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Takeda Pharmaceutical's Variance of 0.7698, coefficient of variation of (804.59), and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide.
At this time, Takeda Pharmaceutical's Capital Stock is quite stable compared to the past year. Stock Based Compensation is expected to rise to about 74.4 B this year, although the value of Sale Purchase Of Stock will most likely fall to (2.4 B). . Price To Free Cash Flows Ratio is expected to rise to 36.51 this year, although the value of Price To Sales Ratio will most likely fall to 1.45. Takeda Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of October 2008 | 200 Day MA 13.8792 | 50 Day MA 14.026 | Beta 0.464 |
Takeda |
Sharpe Ratio = -0.1226
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TAK |
Estimated Market Risk
| 0.9 actual daily | 8 92% of assets are more volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Takeda Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Takeda Pharmaceutical by adding Takeda Pharmaceutical to a well-diversified portfolio.
Price Book 0.9513 | Enterprise Value Ebitda 9.0899 | Price Sales 0.0095 | Shares Float 1.6 B | Dividend Share 192 |
Takeda Pharmaceutical Main Headline on 26th of November 2024
Roche to buy cell therapy developer Poseida for 1B by finance.yahoo.com
The deal suggests Roche sees substantial promise in Poseidas technology, as the offer is 215 percent above the biotechs closing share price on Monday.
Takeda Pharmaceutical Valuation on November 26, 2024
It is possible to determine the worth of Takeda Pharmaceutical on a given historical date. On November 26, 2024 Takeda was worth 13.42 at the beginning of the trading date compared to the closed value of 13.44. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Takeda Pharmaceutical stock. Still, in general, we apply an absolute valuation method to find Takeda Pharmaceutical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Takeda Pharmaceutical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Takeda Pharmaceutical's related companies.
| Open | High | Low | Close | Volume | |
| 13.42 | 13.51 | 13.38 | 13.49 | 1,585,831 | |
11/26/2024 | 13.42 | 13.47 | 13.38 | 13.44 | 964,824 |
| 13.49 | 13.63 | 13.49 | 13.57 | 2,240,266 |
| Backtest Takeda Pharmaceutical | | | Takeda Pharmaceutical History | | | Takeda Pharmaceutical Valuation | Previous | Next |
Takeda Pharmaceutical Trading Date Momentum on November 26, 2024
| On November 27 2024 Takeda Pharmaceutical Co was traded for 13.57 at the closing time. Highest Takeda Pharmaceutical's price during the trading hours was 13.63 and the lowest price during the day was 13.49 . The net volume was 2.2 M. The overall trading history on the 27th of November contributed to the next trading period price upswing. The trading price change to the next next day price was 0.97% . The trading price change to current price is 0.37% . |
Takeda Pharmaceutical Fundamentals Correlations and Trends
By evaluating Takeda Pharmaceutical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Takeda Pharmaceutical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Takeda financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Takeda Pharmaceutical Stock history
Takeda Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Takeda is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Takeda Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Takeda Pharmaceutical stock prices may prove useful in developing a viable investing in Takeda Pharmaceutical
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.6 B | 1.3 B | |
| Net Income Applicable To Common Shares | 364.6 B | 382.8 B |
Takeda Pharmaceutical Stock Technical Analysis
Takeda Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Takeda Pharmaceutical Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Takeda Pharmaceutical Co cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Takeda Pharmaceutical November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Takeda Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Takeda Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Takeda Pharmaceutical stock market strength indicators, traders can identify Takeda Pharmaceutical Co entry and exit signals to maximize returns
Takeda Pharmaceutical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Takeda Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Takeda Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Takeda to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.25) | |||
| Treynor Ratio | (31.33) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.049 | Dividend Share 192 | Earnings Share 0.59 | Revenue Per Share 1.4 K | Quarterly Revenue Growth 0.127 |
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.